Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway
Archives of Biochemistry and Biophysics · 2023
DOI: 10.1016/j.abb.2023.109689 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2023. Verfasst von Shuyuan Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Defective autophagy-induced intracellular lipid degradation is causally associated with non-alcoholic fatty liver disease (NAFLD) development. Therefore, agents that can restore autophagy may have potential clinical application prospects on this public health issue. Galanin (GAL) is a pleiotropic peptide that regulates autophagy and is a potential drug for the treatment of NAFLD. In this study, we used an MCD-induced NAFLD mouse model in vivo and an FFA-induced HepG2 hepatocyte model in vitro to evaluate the anti-NAFLD effect of GAL. Exogenous GAL supplementation significantly attenuated lipid droplet accumulation and suppressed hepatocyte TG levels in mice and cell models. Mechanistically, Galanin-mediated reduction of lipid accumulation was positively correlated with upregulated p-AMPK, as evidenced by upregulated protein expressions of fatty acid oxidation-related gene markers (PPAR-α and CPT1A), upregulated expressions of the autophagy-related marker (LC3B), and downregulated autophagic substrate p62 levels. In FFA-treated HepG2 cells, activation of fatty acid oxidation and autophagy-related proteins by galanin was reversed by autophagy inhibitors, chloroquine, and the AMPK inhibitor. Galanin ameliorates hepatic fat accumulation by inducing autophagy and fatty acid oxidation via the AMPK/mTOR pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
- Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: luotao@hospital.cqmu.edu.cn.
Zitieren
APA
Zhu, S., Wang, S., & Luo, T. (2023). Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2023.109689
Vancouver
Zhu S, Wang S, Luo T. Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway. Archives of Biochemistry and Biophysics. 2023. doi:10.1016/j.abb.2023.109689
BibTeX
@article{Zhu2023,
author = {Zhu, Shuyuan and Wang, Shuai and Luo, Tao},
title = {Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway},
journal = {Archives of Biochemistry and Biophysics},
year = {2023},
doi = {10.1016/j.abb.2023.109689}
}
EUVIMED